JP2008506709A5 - - Google Patents

Download PDF

Info

Publication number
JP2008506709A5
JP2008506709A5 JP2007521684A JP2007521684A JP2008506709A5 JP 2008506709 A5 JP2008506709 A5 JP 2008506709A5 JP 2007521684 A JP2007521684 A JP 2007521684A JP 2007521684 A JP2007521684 A JP 2007521684A JP 2008506709 A5 JP2008506709 A5 JP 2008506709A5
Authority
JP
Japan
Prior art keywords
group
peptidomimetic
seq
compound
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007521684A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008506709A (ja
JP5048486B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/025182 external-priority patent/WO2006020040A2/en
Publication of JP2008506709A publication Critical patent/JP2008506709A/ja
Publication of JP2008506709A5 publication Critical patent/JP2008506709A5/ja
Application granted granted Critical
Publication of JP5048486B2 publication Critical patent/JP5048486B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007521684A 2004-07-16 2005-07-15 アポリポタンパク質a1の模倣物とその使用 Expired - Fee Related JP5048486B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58872204P 2004-07-16 2004-07-16
US60/588722 2004-07-16
PCT/US2005/025182 WO2006020040A2 (en) 2004-07-16 2005-07-15 Apolipoprotein a1 mimetics and uses thereof

Publications (3)

Publication Number Publication Date
JP2008506709A JP2008506709A (ja) 2008-03-06
JP2008506709A5 true JP2008506709A5 (https=) 2008-09-04
JP5048486B2 JP5048486B2 (ja) 2012-10-17

Family

ID=35907926

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007521684A Expired - Fee Related JP5048486B2 (ja) 2004-07-16 2005-07-15 アポリポタンパク質a1の模倣物とその使用

Country Status (12)

Country Link
US (3) US7569546B2 (https=)
EP (1) EP1771473B1 (https=)
JP (1) JP5048486B2 (https=)
KR (1) KR101185609B1 (https=)
CN (1) CN101076541A (https=)
AU (1) AU2005275009B2 (https=)
BR (1) BRPI0513402A (https=)
CA (1) CA2574007A1 (https=)
IL (1) IL180733A (https=)
NO (1) NO20070876L (https=)
TW (1) TWI377066B (https=)
WO (1) WO2006020040A2 (https=)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8568766B2 (en) 2000-08-24 2013-10-29 Gattadahalli M. Anantharamaiah Peptides and peptide mimetics to treat pathologies associated with eye disease
US7723303B2 (en) * 2000-08-24 2010-05-25 The Regents Of The University Of California Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
US7148197B2 (en) * 2000-08-24 2006-12-12 The Regents Of The University Of California Orally administered small peptides synergize statin activity
US7199102B2 (en) 2000-08-24 2007-04-03 The Regents Of The University Of California Orally administered peptides synergize statin activity
KR101185609B1 (ko) * 2004-07-16 2012-09-24 트러스티즈 오브 터프츠 칼리지 아포리포단백질 a1 미메틱 및 이의 용도
AU2005287004B2 (en) * 2004-09-16 2011-03-17 The Regents Of The University Of California G-type peptides and other agents to ameliorate atherosclerosis and other pathologies
KR20070089996A (ko) 2004-12-06 2007-09-04 더 리전트 오브 더 유니버시티 오브 캘리포니아 세동맥의 구조 및 기능의 개선 방법
US20080293639A1 (en) * 2005-04-29 2008-11-27 The Regents Of The University Of California Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
MX2007013430A (es) * 2005-04-29 2008-03-19 Univ California Peptidos y peptidos mimeticos para tratar patologias caracterizadas por una respuesta inflamatoria.
ES2402823T3 (es) * 2006-06-01 2013-05-09 Institut De Cardiologie De Montreal Compuesto para uso en el tratamiento de estenosis valvular
AU2007284801A1 (en) * 2006-08-08 2008-02-21 The Regents Of The University Of Californina Salicylanilides enhance oral delivery of therapeutic peptides
CA2672131C (en) * 2006-12-13 2016-06-07 The Regents Of The University Of California Potent and selective mediators of cholesterol efflux
WO2009032702A2 (en) 2007-08-28 2009-03-12 Uab Research Foundation Synthetic apolipoprotein e mimicking polypeptides and methods of use
EP2195331B1 (en) 2007-08-28 2013-11-20 Uab Research Foundation Synthetic apolipoprotein e mimicking polypeptides and methods of use
WO2009036460A2 (en) * 2007-09-14 2009-03-19 Ambrx, Inc. Modified human apolipoprotein a-i polypeptides and their uses
US7985728B1 (en) 2007-09-20 2011-07-26 Abbott Cardiovascular Systems Inc. Sustained release of Apo A-I mimetic peptides and methods of treatment
US7985727B1 (en) * 2007-09-20 2011-07-26 Abbott Cardiovascular Systems Inc. Apo A-I mimetic peptides and methods of treatment
US9173890B2 (en) 2007-09-20 2015-11-03 Abbott Cardiovascular Systems Inc. Sustained release of Apo A-I mimetic peptides and methods of treatment
CN105903029A (zh) * 2007-12-12 2016-08-31 大学健康网络 高密度脂蛋白样肽磷脂支架(“hpps”)纳米颗粒
AU2014268255B2 (en) * 2009-02-16 2016-04-21 Cerenis Therapeutics Holding Sa Apolipoprotein a-i mimics
JP5719783B2 (ja) * 2009-02-16 2015-05-20 セレニス セラピューティクス ホールディング エスアー アポリポタンパクa−i模倣物
US20130310304A1 (en) * 2010-06-15 2013-11-21 Matthew C. Lawyer Compositions and methods for the treatment of atherosclerosis
HUE042314T2 (hu) * 2011-02-07 2019-06-28 Cerenis Therapeutics Holding Sa Lipoprotein komplexek és azok gyártása és alkalmazásai
JP6549554B2 (ja) 2013-03-15 2019-07-24 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア コレステロール流出を刺激する、減少した毒性を有するペプチド
CN103910802B (zh) * 2014-04-24 2017-01-11 华中科技大学 一种促进树突细胞摄取抗原肽的多肽、促进树突细胞摄取抗原肽的纳米颗粒及其应用
WO2016018665A1 (en) 2014-07-31 2016-02-04 Uab Research Foundation Apoe mimetic peptides and higher potency to clear plasma cholesterol
FR3026409B1 (fr) * 2014-09-26 2018-03-30 Centre National De La Recherche Scientifique (Cnrs) Procede de criblage de molecules interferentes
JP2018516847A (ja) 2015-03-25 2018-06-28 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 生体高分子薬を送達するための組成物及び方法
US12257352B2 (en) 2016-06-20 2025-03-25 The Regents Of The University Of Michigan Compositions and methods for delivery of biomacromolecule agents
TW202130652A (zh) * 2017-01-19 2021-08-16 美國衛生與公眾服務部 Apoc-ii擬肽
MX2022012969A (es) 2020-04-16 2022-11-09 Abionyx Pharma Sa Metodos para el tratamiento de condiciones agudas usando complejos basados en proteinas de union a lipidos.
IL301769A (en) 2020-10-01 2023-05-01 Abionyx Pharma Sa Methods for treating eye diseases using lipid binding protein-based complexes
MX2023012223A (es) 2021-04-15 2023-10-26 Abionyx Pharma Sa Uso de complejos a base de proteinas de union a lipidos en soluciones de conservacion de organos.
CN119317440A (zh) 2022-04-06 2025-01-14 阿比奥尼克斯制药公司 使用基于脂质结合蛋白的复合物治疗白细胞增多、内皮功能障碍和心脏炎的方法
AU2023250345A1 (en) 2022-04-06 2024-11-14 Abionyx Pharma Sa Methods for treating eye diseases using lipid binding protein-based complexes
IL317448A (en) 2022-06-10 2025-02-01 Abionyx Pharma Sa Methods for treating hyperinflammatory conditions using complexes based on lipid-binding proteins
JP2025519606A (ja) 2022-06-10 2025-06-26 アビオニクス ファーマ エスエー 脂質結合タンパク質に基づく複合体を使用して急性状態を処置するための方法
IL322074A (en) 2023-01-13 2025-09-01 Abionyx Pharma Sa Treatment using a lipid-binding protein molecule
WO2025093929A1 (en) 2023-10-31 2025-05-08 Abionyx Pharma Sa Lipid binding protein molecule therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854204A (en) * 1995-03-14 1998-12-29 Praecis Pharmaceuticals, Inc. Aβ peptides that modulate β-amyloid aggregation
US6664230B1 (en) 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
US7105635B2 (en) * 2002-06-04 2006-09-12 The University Of Toledo Cyclic beta-sheet peptides useful as apoptotic/cytotoxic cancer agents
KR101185609B1 (ko) * 2004-07-16 2012-09-24 트러스티즈 오브 터프츠 칼리지 아포리포단백질 a1 미메틱 및 이의 용도
AU2005287004B2 (en) * 2004-09-16 2011-03-17 The Regents Of The University Of California G-type peptides and other agents to ameliorate atherosclerosis and other pathologies
KR20070089996A (ko) * 2004-12-06 2007-09-04 더 리전트 오브 더 유니버시티 오브 캘리포니아 세동맥의 구조 및 기능의 개선 방법

Similar Documents

Publication Publication Date Title
JP2008506709A5 (https=)
JP6223377B2 (ja) 長期間作用性ペプチド類似体のための組成物
JP2006508179A5 (https=)
WO2012050227A1 (en) Peptide derivative
AU2007284801A1 (en) Salicylanilides enhance oral delivery of therapeutic peptides
JP2011518179A5 (https=)
RU2007110981A (ru) Урокортин iii и его использование
RU2009110452A (ru) Галеновые составы алискирена
AR025307A1 (es) Compuesto de liberacion sostenida de un peptido, microparticulas, composicion farmaceutica y el uso de dicho compuesto para la fabricacion de un medicamento
JP2008522980A5 (https=)
DK2783697T3 (en) VIP Fragments and uses thereof
JP2022543826A5 (https=)
JP2009523156A5 (https=)
JP2024532403A5 (https=)
JP2007506713A (ja) 例えば、抗血管新生活性を有するペプチドおよび治療におけるその適用
JP2010513311A5 (https=)
ES2349153T3 (es) Inhibidores del virus de la hepatitis c.
SK150196A3 (en) Peptides with immunomodulatory effects, pharmaceutical formulations containing them and their use
JP2010534238A (ja) プラスミノーゲン活性化因子阻害物質1由来のペプチドおよびその使用
JP2005514385A (ja) プリオン阻害ペプチド及びその誘導体
CN101657465B (zh) 肽、组合物及其应用
CN114364691B (zh) 作为纤维化基质积累的抑制剂的肽
US6908900B2 (en) Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients
US6596692B1 (en) Substance P analogs for the treatment of cancer
JP2023541087A5 (https=)